Impairment analysis under ASC 350-20, ASC 350-30, and ASC 360-10 is required for a company following U.S. GAAP and is important for several reasons, including accurate financial reporting, regulatory compliance, and stakeholder confidence. In response to recent international conflicts, regulatory uncertainty, and market volatility, a company can mitigate the risk of inaccurate impairment analysis by working with Andersen to reevaluate the company’s process and approach for identifying triggering events and performing impairment testing. Below is a summary of these important provisions.

Download the PDF to learn more.